Huntington Business Credit Closes Credit Facility with Spirit Pharmaceuticals, LLC

Huntington Business Credit announced it closed a $20,000,000 new credit facility with Spirit Pharmaceuticals, LLC on July 6, 2022.  Proceeds of the facility were used to refinance existing indebtedness and provide ongoing working capital growth financing.              

Spirit Pharmaceuticals, LLC, headquartered in Ronkonkoma, New York, is a packager and wholesaler of private label over the counter (“OTC”) pharmaceutical products.                     

Huntington Business Credit provides working capital and term loan facilities to middle market companies for acquisitions, LBO’s, MBO’s recapitalizations, rapid growth, seasonal working capital build-up, and turnaround situations.